Cargando…

Prevalence of metabolic syndrome and its components in Brazilian adolescents: a systematic review and meta-analysis

OBJECTIVE: To determine the prevalence of metabolic syndrome (MS) and its components among Brazilian adolescents. DATA SOURCE: Databases, such as LILACS, MEDLINE, and SciELO, were searched for original cross-sectional studies published between 2010 and 2021. The inclusion criteria were determined ba...

Descripción completa

Detalles Bibliográficos
Autores principales: de Paiva, Miguel Henrique Pereira, Miranda, Valberto Alencar, de Oliveira, Ana Raquel Soares, Cruz, Kyria Jayanne Clímaco, de Araújo, Regina Maria Sousa, de Oliveira, Karla Andrade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade de Pediatria de São Paulo 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273121/
https://www.ncbi.nlm.nih.gov/pubmed/35830158
http://dx.doi.org/10.1590/1984-0462/2023/41/2021145
Descripción
Sumario:OBJECTIVE: To determine the prevalence of metabolic syndrome (MS) and its components among Brazilian adolescents. DATA SOURCE: Databases, such as LILACS, MEDLINE, and SciELO, were searched for original cross-sectional studies published between 2010 and 2021. The inclusion criteria were determined based on the mnemonic CoCoPop — Condition, Context, and Population: studies determining the prevalence of MS and its components (condition) in the general population of Brazilian adolescents, female and male (population), enrolled in public or private schools in rural or urban areas (context). Reviews, editorials, and articles that did not directly relate to the prevalence of MS or that included non-adolescent age groups or groups with specific health conditions (obesity/overweight and others) were excluded. DATA SYNTHESIS: A total of 15 studies, including 43,227 adolescents, were identified. MS prevalence (95% confidence interval [95%CI]) was 2.9% (2.65–3.18) and 2.4% (1.90–2.90) (p<0.001) in males and females, respectively, by using the International Diabetes Federation (IDF) criteria. There was a significant difference in MS prevalence among Brazilian regions (Q=24.7; p<0.001). The lowest MS prevalence (95%CI) was determined for North Region of Brazil, 1.8% (1.52–2.13), and the highest for Northeast Region of Brazil, 2.9% (2.62–3.23). Regarding MS components, a higher prevalence (95%CI) was found for low high-density lipoprotein (HDL), 22.1% (12.49–36.17), followed by abdominal obesity, 11.0% (8.05–14.94), and arterial hypertension, 10.3% (7.84–13.48). CONCLUSIONS: This study allowed the determination of the prevalence of MS and the MS components in Brazilian adolescents, highlighting relevant aspects to be addressed on public health management.